Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CARL FERGUSON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1619068681
CMS profile
73039
Location
MESA, AZ

General Payments · PY2018–2024

$10,729.94

  • Reported across 177 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$720.50

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $720.50 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $178.75 16
IMPULSE DYNAMICS (USA) INC. $173.67 1
GlaxoSmithKline, LLC. $107.74 5
ABBVIE INC. $77.26 3
Amgen Inc. $53.83 3
Braeburn Inc. $44.53 2
Acerta Pharma LLC $29.86 2
Abbott Laboratories $20.53 1
FIDIA PHARMA USA INC. $20.38 1
Inspire Medical Systems, Inc. $13.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $540.18 30
PY2019 $383.67 28
PY2020 $7,902.34 18
PY2021 $351.41 21
PY2022 $488.75 27
PY2023 $343.09 18
PY2024 $720.50 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $20.53 01/31/2024 Food and Beverage Undisputed 01/23/2026 1125152441 CMS
ABBVIE INC. $33.46 05/02/2024 Food and Beverage Undisputed 01/23/2026 1103721338 CMS
ABBVIE INC. $13.44 07/18/2024 Food and Beverage Undisputed 01/23/2026 1103721340 CMS
ABBVIE INC. $30.36 07/24/2024 Food and Beverage Undisputed 01/23/2026 1103721342 CMS
Amgen Inc. $18.26 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117250201 CMS
Amgen Inc. $17.48 03/27/2024 Food and Beverage Undisputed 01/23/2026 1117250203 CMS
Amgen Inc. $18.09 07/22/2024 Food and Beverage Undisputed 01/23/2026 1117250205 CMS
AstraZeneca Pharmaceuticals LP $16.52 02/21/2024 Food and Beverage Undisputed 01/23/2026 1104584012 CMS
AstraZeneca Pharmaceuticals LP $13.34 08/29/2024 Food and Beverage Undisputed 01/23/2026 1104744329 CMS
Braeburn Inc. $22.69 03/06/2024 Food and Beverage Undisputed 01/23/2026 1125599677 CMS
Braeburn Inc. $21.84 07/18/2024 Food and Beverage Undisputed 01/23/2026 1125599679 CMS
Fidia Pharma USA Inc. $20.38 01/10/2024 Food and Beverage Undisputed 01/23/2026 1141157233 CMS
GlaxoSmithKline, LLC. $21.84 02/15/2024 Food and Beverage Undisputed 01/23/2026 1115757600 CMS
GlaxoSmithKline, LLC. $24.92 05/08/2024 Food and Beverage Undisputed 01/23/2026 1116537070 CMS
GlaxoSmithKline, LLC. $23.37 08/14/2024 Food and Beverage Undisputed 01/23/2026 1115887361 CMS
GlaxoSmithKline, LLC. $18.95 09/18/2024 Food and Beverage Undisputed 01/23/2026 1116612135 CMS
GlaxoSmithKline, LLC. $18.66 11/04/2024 Food and Beverage Undisputed 01/23/2026 1116574264 CMS
Impulse Dynamics (USA) Inc. $173.67 02/12/2024 Food and Beverage Undisputed 01/23/2026 1100421031 CMS
Inspire Medical Systems, Inc. $13.95 12/23/2024 Food and Beverage Undisputed 01/23/2026 1148053796 CMS
Novo Nordisk Inc $13.64 01/06/2024 Food and Beverage Undisputed 01/23/2026 1097420652 CMS
Novo Nordisk Inc $21.40 01/29/2024 Food and Beverage Undisputed 01/23/2026 1096818621 CMS
Novo Nordisk Inc $7.57 02/26/2024 Food and Beverage Undisputed 01/23/2026 1097008886 CMS
Novo Nordisk Inc $12.79 03/17/2024 Food and Beverage Undisputed 01/23/2026 1096713285 CMS
Novo Nordisk Inc $12.13 05/22/2024 Food and Beverage Undisputed 01/23/2026 1097524949 CMS
Novo Nordisk Inc $5.35 05/23/2024 Food and Beverage Undisputed 01/23/2026 1097209933 CMS
Novo Nordisk Inc $17.17 06/26/2024 Food and Beverage Undisputed 01/23/2026 1097553363 CMS
Novo Nordisk Inc $7.25 07/30/2024 Food and Beverage Undisputed 01/23/2026 1096934759 CMS
Novo Nordisk Inc $15.82 09/10/2024 Food and Beverage Undisputed 01/23/2026 1097459825 CMS
Novo Nordisk Inc $1.36 09/30/2024 Food and Beverage Undisputed 01/23/2026 1096922942 CMS
Novo Nordisk Inc $3.28 09/30/2024 Food and Beverage Undisputed 01/23/2026 1097235266 CMS
Novo Nordisk Inc $16.27 10/07/2024 Food and Beverage Undisputed 01/23/2026 1096579943 CMS
Novo Nordisk Inc $8.84 10/21/2024 Food and Beverage Undisputed 01/23/2026 1097311937 CMS
Novo Nordisk Inc $9.83 10/21/2024 Food and Beverage Undisputed 01/23/2026 1097398270 CMS
Novo Nordisk Inc $19.03 10/29/2024 Food and Beverage Undisputed 01/23/2026 1096953677 CMS
Novo Nordisk Inc $7.02 12/16/2024 Food and Beverage Undisputed 01/23/2026 1097707034 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.